| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 03/14/2002 | WO2001055130A3 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 03/14/2002 | US20020032348 Bactericides; reacting imine, carbamate, ester, amide and epoxide derivatives |
| 03/14/2002 | US20020032237 Antipicornaviral compounds, compositions containing them, and methods for their use |
| 03/14/2002 | US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/14/2002 | US20020032192 Treatment of vasodilatory headache |
| 03/14/2002 | US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/14/2002 | US20020031816 Method of inhibition of human glycogen phosphorylase |
| 03/14/2002 | DE10065434A1 Indole Indoles |
| 03/14/2002 | DE10043659A1 Arylpiperazinderivate Arylpiperazinderivate |
| 03/14/2002 | DE10042736A1 Wirkstoffkombinationen mit insektiziden und akariziden Eigenschaften Drug combinations with insecticidal and acaricidal properties |
| 03/14/2002 | DE10042696A1 New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis |
| 03/14/2002 | CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | CA2419958A1 Substituted fused pyrroleimines and pyrazoleimines |
| 03/13/2002 | EP1186318A2 Combination, for treating depression and anxiety, containing a 5HT1d receptor antagonist and aCNS penetrant NK-1 receptor antagonist |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | EP0975219B1 Fungicide active substance combinations |
| 03/13/2002 | EP0948483B1 Farnesyl transferase inhibitors |
| 03/13/2002 | EP0770067B1 Substituted cinnamic oxime and hydroxamide derivatives |
| 03/13/2002 | CN1080719C Substituted 1H-3-aryl-pyrrolidine-2,4-diones derivatives |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355799 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
| 03/12/2002 | US6355680 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
| 03/12/2002 | US6355648 Thio-oxindole derivatives |
| 03/12/2002 | US6355644 Nervous system disorders and treatment of schizophrenia and bipolar disorder |
| 03/12/2002 | US6355642 Tetrahydrobenzindole compounds |
| 03/07/2002 | WO2002018455A1 Resins having vinyl ether linker for the solid phase organic synthesis |
| 03/07/2002 | WO2002018369A2 Peptidomimetic protease inhibitors |
| 03/07/2002 | WO2002018327A2 Guanidinobenzamides as mc4-r agonists |
| 03/07/2002 | WO2002018323A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2002018321A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2002018319A1 Process for making n-aryl-anthranilic acids and their derivatives |
| 03/07/2002 | WO2002017914A2 Fused pyrrolocarbazoles against inflammation |
| 03/07/2002 | WO2002017715A1 Active ingredient combinations comprising insecticidal and acaricidal properties |
| 03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
| 03/07/2002 | WO2001058471A3 Novel amino acid and peptide inhibitors of staphylococcus virulence |
| 03/07/2002 | WO2001044182A3 New synthesis of spla2 inhibitors |
| 03/07/2002 | WO2001015673A3 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 03/07/2002 | US20020028940 Also benzimidazolyl and imidazo(4,5-b)pyridinyl-substituted; amides; antiatherosclerotic; reduces smooth muscle cell proliferation as well as reduction in lipoproteins, cholesterol and triglycerides |
| 03/07/2002 | US20020028936 1,3-disubstituted indolin-2-ones for neoplasia |
| 03/07/2002 | US20020028840 2-indolinone derivatives as modulators of protein kinase activity |
| 03/07/2002 | US20020028836 Potassium channel openers |
| 03/07/2002 | US20020028833 Aryl alkenamides derivatives as mcp-1 antagonists |
| 03/07/2002 | US20020028828 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | US20020028821 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 03/07/2002 | US20020028810 Substituted N-( indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 03/07/2002 | US20020028803 Controlling cell apoptosis |
| 03/07/2002 | US20020028799 Using protease and phospodiesterase inhibitor |
| 03/07/2002 | US20020028774 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/07/2002 | DE10041903A1 New aconitic acid derivatives useful as ultraviolet absorbers, fluorescent dyes, marker dyes, optical brighteners and intermediates for pharmaceutical, veterinary or plant protection agents |
| 03/07/2002 | CA2697205A1 Peptidomimetic protease inhibitors |
| 03/07/2002 | CA2420003A1 Process for making n-aryl-anthranilic acids and their derivatives |
| 03/07/2002 | CA2416740A1 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/06/2002 | EP1184373A1 Tricyclic compounds |
| 03/06/2002 | EP1184358A2 Process for treatment and purification of the reaction products obtained by reduction with lithium aluminium hydride |
| 03/06/2002 | EP1183234A1 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183232A2 Monofluoroalkyl derivatives |
| 03/06/2002 | EP1183231A1 Cytofectin dimers and methods of use thereof |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof |
| 03/06/2002 | EP0740657B1 4-arylisoindole analgesics |
| 03/06/2002 | CN1339025A Indole derivatives and their use as MCP-1 antagonists |
| 03/06/2002 | CN1080261C 3-substituted 1-arylindole compounds |
| 03/06/2002 | CN1080259C Process for preparing cyclic compounds |
| 03/06/2002 | CN1080258C 1-H-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents |
| 03/06/2002 | CA2356797A1 Combination treatment for depression and anxiety |
| 03/05/2002 | US6353136 Process for preparing aromatic amines in the presence of palladaphosphacyclobutane catalysts |
| 03/05/2002 | US6353124 Nonsteroidal antiinflammatory agents (aspirin, indomethacin, or ibuprofen) linked by tris amine or ethanolamine derivative to the acyl groups of fatty acids; improved transdermal delivery |
| 03/05/2002 | US6353109 Psychological disorders; sleep disorders; anticonvulsants; cognition activators |
| 03/05/2002 | US6353099 Substituted ureas as cell adhesion inhibitors |
| 03/05/2002 | US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents |
| 03/05/2002 | US6353007 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| 03/05/2002 | US6352988 High affinity for d4 receptors; treatment of schizophrenia, other psychoses, anxiety disorders, depression, alcohol abuse, impulse control disorders, aggression |
| 03/05/2002 | US6352985 Benzimidazole compounds |
| 03/05/2002 | US6352958 Pre- and post-emergence herbicides |
| 03/05/2002 | CA2266565C Azabicyclic rotomase inhibitors |
| 03/05/2002 | CA2215013C N-substituted indol-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action |
| 03/05/2002 | CA2207574C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 02/28/2002 | WO2002016349A1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders |
| 02/28/2002 | WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016317A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016313A2 Integrin receptor inhibitors |
| 02/28/2002 | WO2002016311A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 02/28/2002 | WO2002016310A1 Selective androgen receptor modulators and methods of use thereof |
| 02/28/2002 | WO2002015891A2 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors |
| 02/28/2002 | WO2001087887A3 Neuroprotective and anti-proliferative compounds |
| 02/28/2002 | WO2001068593A3 Amino acid derivatives as hiv aspartyl protease inhibitors |
| 02/28/2002 | WO2001064639A3 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 02/28/2002 | WO2001042216A3 Caspase inhibitors and uses thereof |
| 02/28/2002 | WO2001023354A3 Trifluoromethyl-substituted spirocyclic ketoenols and use thereof as pesticides and herbicides |
| 02/28/2002 | US20020026053 Novel 3-(substituted) -2- indolinones compounds and use thereof as inhibitors of protein kinase activity |
| 02/28/2002 | US20020025977 Psychological disorders; nervous system disorders |
| 02/28/2002 | US20020025973 Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists |
| 02/28/2002 | US20020025965 Antiserotonine agents |
| 02/28/2002 | US20020025948 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 02/28/2002 | US20020025935 Antiinflammatory agents; autoimmune diseases; central nervous system disorders |
| 02/28/2002 | CA2419580A1 Integrin receptor inhibitors |
| 02/28/2002 | CA2419266A1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders |
| 02/28/2002 | CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |